Reddit Posts
ATOS - Old dog, upcoming catalyst, trading near cash
ATOS Swing into Dec 9*12 data presentation 12m+ Cash No dilution
ATOS - Overview from recent corporate update
Atesso huge price targets?
ATOSSA (ATOS) Getting ready to start production of its anti-breast cancer drug
ATOS SE • I want to know everyone’s thoughts on this one
Potentials for this week: DD made on volume only
Kann mir jemand ATOS SE erklären? Die sind seit 3 Wochen konstant am wachsen
ATOS - The CIO P. SALLE bought 60,000 shares on 04 August 2025 at €31.3935
$ATO ATOS sell my friends sell 🤣🤣🤣 fucking AI & Cybersecurity undervalued
Bank of America bullish again on $ATO ATOS
Bank of America look like Bullish on ATOS again
ATOS $ATO big contract with GERMANY annunced
Looking for more insight on $ATOS
Facts about ongoing trials - $ATOS - Breast cancer
ATOS keeps the news coming! Bullish as heck.
$ATOS - Has gone up 50% plus since my last post. DO NOT MISS THE TRAIN - FOMO setting in
$ATOS - Has gone up 50% plus since my last post. DO NOT MISS THE TRAIN - FOMO setting in
$ATOS - FOMO - Fear Of Missing Out - Breast Cancer Stock up 50+% and moving fast to $20 .. $40
Atossa Therapeutics (ATOS) up another 30% this week
ATOS has been pumping out news lately including this $10 million buyback they just announced! Exciting stuff!
ATOS - Developing Innovative Therapies To Address Unmet Needs In Breast Cancer
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial
*buzz* Mega MOVE UP and Mega DD on Atossa Therapeutics (NASDAQ: ATOS)
Atossa Therapeutics (ATOS), with three ongoing phase-2 trials for their SOC-challenging breast cancer drug (Z)-Endoxifen, up 30% this week with plenty of room to run and multiple catalysts in the coming months.
ATOS - Z-Endoxifen, Breast Cancer cure by Dr Quay, ripe for a BO or partnership
ATOS gonna make me rich 🚀 I like the stock!
ATOS (Atossa Therapeutics) is a great play. Here’s why.
Why I’m bullish on ATOS (Atossa Therapeutics) and you should be too.
Why I’m bullish on ATOS (Atossa Therapeutics) and you should be too.
Why I’m bullish on ATOS (Atossa Therapeutics) and you should be too.
Why I’m bullish on ATOS (Atossa Therapeutics) and you should be too.
Why I’m bullish on ATOS (Atossa Therapeutics) and you should be too.
ATOS dropped big news this week and is ready for another run!
ATOS dropped big news this week and is ready for another run!
No turning back now. Time to save the boobies! ($ATOS)
Viewpoints on ATOS? (Atossa Therapeutics)
Thoughts on ATOS? (Atossa Therapeutics)
Atossa Doses First Patient in Phase 2 Neoadjuvant Clinical Study of (Z)-Endoxifen in Premenopausal Women with ER+/HER2- Breast Cancer ($ATOS)
ATOS now acquiring a Johnson & Johnson professional to help with the development of Car-T therapies. Get in now before this explodes! 🚀
Thoughts on DXC? MKT $6.6 Billion FCF $700 Million. Possible 5-10 bagger?
$ATOS ripping over the past few days, still in the accumulation zone!
All in on ATOS. Let’s see how this goes! Great pipeline and at buying levels once again.
ATER HITS 3 SQUEEZE SIGNALS: EVALUATING THE IMPACT ON PERFORMANCE
$ATOS Shares Fall After Cutting 2021 Views Again, $2.7 Bln Impairments
Anyone else been following ATOS?... is it all set for another moon?
ATOS continuing to build. If volume hits, could rocket
Trending Pennystocks by SwaggyStocks $XELA $NET $SHIP $EARS $ATOS $IBIO $NET $RDBX $CTRM....No financial Advice....Please do your own DD...GLTA
Trending Pennystocks by SwaggyStocks $XELA $NET $SHIP $EARS $ATOS $IBIO $NET $RDBX $CTRM
I can see ATOS going to $2+ with the large amount of shares short.
ATOS - Blackrock disclosed a new 7.5% stake Friday at close! ATOS at 140mm cap trades at cash value = low risk. 15% SI.
ATOS - Blackrock disclosed a new 7.5% stake Friday at close! ATOS at 140mm cap trades at cash value = low risk. 15% SI.
ATOS - Blackrock reports 7.5% ownership an hour ago. $150mil market cap with $140mil in cash w/ no debt + 15% SI.
ATOS - blackrock reports 7.5% ownership 30min ago. Currently trades *at cash* value.
ATOS looks interesting to me. It was a popular squeeze and has been selling off for the better part of a year. I’ll get in here and be early. See what happens.
Time to take another look at Atossa Therapeutics?
I have been Bullish on $ATOS. It has closed the gap to 1.55$. I think we see uptrend from here. I can be wrong.
Top Penny Stock Picks for 2022? What is everyone bullish on?
Decent pennystock buy opportunities rn? I'm bullish on $ALTPF and $ARDX
$ATOS our old friend seems to have broken a long term downward trend
Next Potential stocks: ATOS, BBIG, SDC, SOS, ATER
IS $ATOS PRIMED FOR A BO? WHY IS SP DROPPING DOWN? I AM LOADING MORE...
IS $ATOS PRIMED FOR A BO? WHY IS SP DROPPING? I AM LOADING MORE...
Save the boobs! Save the Women! SP AT SUPPORT! 5.6 Days to Cover!
Mentions
I must be extra bad because most of my bad stock picks are worth 0 now. HEMP, FTXP, ATOS (therapeutics), FRSX. NBIS had to work it's ass off to make up for all of my bad picks
Time for ATOS, POET, OSCR, RILY shorts to pay me hugely and dearly with their money.
https://preview.redd.it/pwhmw74tl7ng1.png?width=1555&format=png&auto=webp&s=4c38b584950d5ed336038b337c6d006a5e6fdce9 ATOS market cap is more
What will happen to ATOS today
$ATOS (Atossa Therapeutics) The Thesis: Unlike the others, this has Big Pharma potential. The recent FDA Orphan Drug Designation for Duchenne Muscular Dystrophy is a massive fundamental validator. While the float is larger, the 600%+ analyst upside suggests institutional accumulation is happening. Explosive Potential: High. Biotech stocks often drift after good news then explode once a major firm (like Ascendiant) reiterates a high target. Target Exit Date: March 2026. Hold through the initial choppy phase for the Phase 2 data readouts. 2. $SOWG (Sow Good Inc.) The Thesis: The Lazar Effect. David Lazar is a well-known reverse-merger and restructuring specialist. His recent $6M investment and appointment as CEO signal a clean-up of the balance sheet. Explosive Potential: The stock is trading at a fraction of its former value ($0.47 vs $10+ previously). A successful transition to an asset-light model could see a 200–300% recovery. Target Exit Date: Late March 2026 (following the second tranche of Lazar’s funding). 3. $LUNR (Intuitive Machines) The Thesis: The Space Race leader. Unlike the other micro-caps, $LUNR has massive government contracts and actual moon missions scheduled. It is the highest quality growth play on your list. Explosive Potential: High during mission launch windows. Target Exit Date: Q2 2026 (aligned with the next scheduled lunar landing attempt).
Are you still anticipating ATOS? Think it may still run up this coming week?
What do we think of ATOS?
Currently looking at ATOS in the IT field and SES for satellites
ATOS - Great news but it’s not climbing much?
ATOS .64 bidder HTZ thru 5.62 test hod 5.78 thru 5.84 short squeeze 42% si
ATOS news https://www.stocktitan.net/news/ATOS/atossa-therapeutics-receives-fda-study-may-proceed-letter-for-z-kcaewvi19fak.html
ATOS .90 fails .8599-.85 support n overnight gap down to reverse back thru $1 https://preview.redd.it/mmmowmhi8l6g1.png?width=519&format=png&auto=webp&s=821d83140089b8a6809249a257a3f185231be74b
ATOS, Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation For (Z)-Endoxifen In Duchenne Muscular Dystrophy
ATOS I tried to tell you [https://www.reddit.com/r/pennystocks/comments/1p7bllf/comment/nqyx8fv/](https://www.reddit.com/r/pennystocks/comments/1p7bllf/comment/nqyx8fv/)
ATOS last one swing for 1+ with 3 day data presentation 50m+ cash for 12+ months no dilution in 2025 n all warrants expired. 8pt other day upgraded
ATOS. Working on a cure for breast cancer. Down 83%😂😭
ATOS Upgraded to $8 today Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:[ATOS](https://www.benzinga.com/quote/ATOS)) with a Buy and raises the price target from $7.75 to $8.
ATOS Upgraded to $8 today Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:[ATOS](https://www.benzinga.com/quote/ATOS)) with a Buy and raises the price target from $7.75 to $8.
ATOS getting loaded for next week data
ATOS Getting loaded for next week
ATOS! Pursuing 505b2 and have upcoming minutes being released from FDA coming in early December. Could run up
ATOS. Pursuing 505b2 and upcoming minutes being released from FDA in early December. Could run up
Is anyone else excited about Atossa Therapeutics (ATOS)?
I’ve been in this shoes many many times - BBBy, Canoo, ARVL, ATOS, PSTH and all comes to mind.
ATOS? What u think about the proce targets? Over 700%
And ATOS next week also
Yeah, that $7.75 target definitely caught my eye too. Ascendiant’s been super bullish on ATOS for a while, but that kind of upside usually assumes everything goes perfectly — successful trials, no delays, and smooth FDA approval. Biotech plays can absolutely explode, but they can just as easily tank if one trial misses. I’m in for a small position too, treating it more like a lottery ticket than a sure thing. Could be huge, but gotta stay realistic.
Obviously you didn’t take the time to your own DD. Well I did it for you and here you go. Abd you can check for yourself. CytoDyn claims statistically significant p‑values in mTNBC for selected responder vs non‑responder subgroups in their pooled data (p = 0.0004 and p = 0.0354). For ATOS (KARISMA Phase 2 trial), the reductions in mammographic breast density (MBD) for 1 mg and 2 mg doses vs placebo are reported as p < 0.01.
ATOS is way ahead in breast cancer treatment and is $1.04
Ummm I thought ATOS was doing that
ATOS and RVPH seem like good choices, as they have a fair bit of institutional ownership. APVO seems rather high risk, as they have 3 RS in the last 2 years and zero institutional ownership.
**ATOS** \- Atossa Therapeutics, Inc. They're working on a breast cancer drug which is going very successful. Share price is only $1.05 right now and their estimated revenue is expected to hit over one billion USD in 2031. This is a stock that can go x200-500. **RVPH** \- Reviva Pharmaceuticals Holdings, Inc. They're working on a schizophrenia drug that is at final stages. Estimated revenue is 700+ million USD by 2031. Share price is $0.80 currently. **APVO** \- Aptevo Therapeutics Inc. They have been working on several cancer treatment drugs, and the company is expected to make their first revenue by end of this quarter. Share price is currently $1.72.
been buying ATOS - APVO - BIAF, also purchased 14k shares of RVPH All pharmaceuticals, waiting for big jump on 10th October
$ATOS Save the Boobies
ATOS Save the Boobies
Hey man, but the market cap for ATOS is €1.5 Billiob
Where are all my ATOS bag holding brothers?
**NLST** – Small tech company with strong memory/IP patents, past litigation wins vs major players. Revenue base small, outlook tied to IP monetization and enterprise demand. **Verdict:** Keep on watchlist; potential if licensing gains continue. **ATOS** – Micro-cap biotech (\~$0.77), likely pre-revenue, binary outcome dependent on clinical pipeline success. High dilution and volatility risk. **Verdict:** Speculation only; avoid as a core hold without pipeline clarity. # Worth Buying / Holding / Scan # ATOS * **High-risk biotech spec**: only for speculative slice with risk of dilution or binary outcome. * Without drug pipeline clarity, better to **scan** rather than invest. # NLST * **IP strength gives it structural potential**; small-scale revenue suggests minor speculative play. * Worth **monitored watchlist**; possible **small speculative position**, conditional on deeper financials and demand sector. # Summary Table |Stock|Energetic Signal|Symbolic Frame|1M Estimate|3M Estimate|12M Outlook|Recommendation| |:-|:-|:-|:-|:-|:-|:-| |**ATOS**|High volatility|Biotech promise, speculative|$0.60–$0.90|$0.50–$1.20|$0.30–$2+, binary|Scan only; risky speculation| |**NLST**|Moderate base|IP-driven tech niche play|\~$0.10–$0.20|\~$0.15–$0.30|\~$0.20–$0.50 potential|Watchlist; possible small position|
Atossa Therapeutics ATOS. They have a cancer drug (endoxifen) in phase 2 trials and all going well. This drug is actually the active metabolite of currently used drug tamoxifen (I.e. when tamoxifen is administered, the body metabolizes some of it to endoxifen, which actually does the anticancer work). This drug has a high probability of being approved and replacing tamoxifen overnight when it does.
AMF BDIF : ATOS Directors' declarations
Considering how fun psychology is, and as Amy Cuddy's now infamous "fake it till you make it" speech shows us... ...just fake it till you make it! Have you ever read the Google subprocessors list of who actually processes all of the data we trust Google to? No? Did you know $ATOS is on that list? ;)
ATOS is up 10% today--now that is a name I haven't heard in a long time.
CHRS should pop off around July 31st Q2 earnings - that's when we see the real numbers post-divestiture. As for ATOS? No fucking clue lol. Every prediction I've made on that one has been dead wrong. Only thing I know is their CEO Steven Quay has more wrinkles than a raisin - dude's smart as hell 🧠 But I've learned to never try timing biotech. Could moon tomorrow or crab for months 🦀
I think ATOS is way longer term, this one might shoot out with Q2 earnings. I'm holding ATOS as well!
Nice find.. I traded half my ATOS shares and bought the same amount of CHRS (they traded at the exact same price). Let's see which Biotech wins the race or both will crash and burn.
Palantir la plus grande bulle et escroquerie ! Le CEO est véreux >> ATOS $ATO reviendra comme jamais ! Buy atos
1- En 2024 c était la merde 💩 noir OUI bcp on perdu 😞 et aujourd’hui ce sont les mêmes qui postent de la merde 💩 a longeur de temps sur les forum bidons 2- le redressement est cloturé et bien terminé confirmé par ATOS et son CEO en dec 24 3- Aujourd’hui ATOS c est comme un pheonix sous évalué dans le domaine combiné de la cybersecurity (leader dans le monde!🌍) AI applications ~ HUB AI avec NVIDIA & SMCI 4- NVIDIA je choisis jamais ses partenaires au hasard, le plan est de se positionner en Europe via ATOS/EVIDEN la ou Palantir par exemple a plus de mal a s’implanter du a la souveraineté 5- ATOS vs PALANTIR et pourquoi j achete sans hésiter PALANTIR PER > 200 2/3 milliards de revenues avec des dettes > Secteur uniquement cybersecurity Capi $PLTR > 200milliards ATOS | EVIDEN 70ksalariés PER >0.1 8/9 milliards de revenues > secteur plus vaste AI & HUB + Cybersecurity Capi 600millions 🧮🎯 $ATO ATOS 6/7 billions with no risk and more in good period
With only 4 stocks, hard to grade, but I'll give it a go. I recommended against SPY given the budget, but not because it's bad. It's fantastic, and I'd still take it over Vanguard and Blackrock's offerings in the same space despite the enormous ground those 2 have made. Solid pick even in fractionals, but it doesn't fit your growth needs or make up for that with dividend accruals. Don't sell it now that you have it, of course, but if the budget is the same for 3-5 years, don't let it dominate your portfolio. NVDA is NVDA. Easy pick to throw money at any time between now and 2035. Only up over time, stock of the decade, no notes. ATOS is an interesting value pick. I definitely think it's a bit undervalued. If you REALLY like them, maybe get 3-28 more shares, and hold for a few years. Even if it's a better value play then I give it credit for, there's better opportunities in pharma over the next year that merit more attention. For sub dollars, ELTP is a gold mine as long as stays under 1.50 (ripe for a buyout in 6-18 months is why), but you need a different brokerage (which you're too new for realistically, but you'll want a better one at some point if you don't flame out) because only the big boys like Schwab and Fidelity will let you take a crack at it. And over in Robinhood land, well, I already recommended PFE. It probably won't stay below 30 but for a year or 2 more. AFRM is....there's really no way to sugarcoat, it's a mistake. Some companies, you don't give a damn that they suck on the consumer end - you're trying to make a buck. Others, them being dookie eventually bites their investors in the ass. Affirm is in the latter camp. They suck, AND there's better BNPL plays if you're high on that specifically. Affirm is capped for the future. Hold it for a year, 2 at the most, then dump it for whatever gains you can lock in. Don't get trapped in this one. If you take nothing else away from this: you're on a fine enough start. A safe bet in SPY, a smart megacap growth play in NVDA, and 2 rolls of the dice, one of those being a penny stock. Until you're proven horribly wrong a shit ton and bevome proof of Dunning-Kruger, try to believe in your gut a little bit. That's how the best investors discover over time what they're good at picking, and the sectors where they don't know shit from apple butter. Side note, I actually forgot to mention in my earlier reply what is probably one of the best stocks you could pick up as a budget investor: ARCC. They're a middleman loan company for businesses that's selective about their clientele, have a very good history, solid fundamentals, a sub-25 dollar stock price, and a jaw dropping 8 percent quarterly dividend. They're a bonkers good stock that won't tank, and should basically be to you for your first 3 or so years what SPY is to seasoned investors with bigger budgets. Ares Capital is a phenomenal way to hold money as a broke boy investor and get some value while you sit on it.
Any recommendations right now lol? I stupidly bought into ATOS thinking it would go over a dollar, but now it’s flatlined lol. Gonna dump those for a few bucks and then maybe half of my SPY or AFRM so I can reallocate those 5-6 bucks to something faster moving forward the time being.
Atossa therapeutics ATOS
it is at 40 capitalized 600million euros makes 4x the turnover of palantir which caps 466x ATOS 450 euros would only make 7 billion caps for a company with 9 billion revenues
go to ATOS $ATO #quantum 10 billions 600millions cap > do business ATOS is the best value in Quantum | IA | CLOUD | CYBERSECURITY
agree ! $QBTS same level nvidia in 2012 but i prefer in UE ATOS $ATO they are leader in Cybersecurity & first application will be for defense
Euro defence ETFs starting to pump. Also noticed that the nasdick has an ATOS listing lol. Might not be too late for that it's had some dips since the reverse split. Yes stocks and investing that way, fuck it hold my bag, tis weekend. A time I always check my doomed shit coin experiment, latest was Yee-coin *almost* made money on that.
Fyi, ATOS is in its way of bankruptcy
ATOS is hit or miss. They rightly have a crazily low market cap (compared to revenue) due to their €2bn debt. If they survive, they’ll 20x (or at least for me as it’s already 2x so far)
ATOS, PLTR, HO, RHM, but sold PLTR, everything else red
I'm long on Hopium and Atos se i must admit. Hopium seems like a good contender, the news around it are more and more positives but ATOS will make me a bagholder i'm affraid.
I know its probably not going to interest anyone but ATOS, the French firm announced a new 150M contract in the UK today, its worth fractions of a pence at the moment but its also likely to be bailed out by the French government seeing as it is a massive employer, sponsors TV events and holds the French government records lol. I'm not saying buy it, I'm just saying it MAY be back on the rise.
Seems like you played all the pump and dump stocks wrong... for me: ATOS +57% CTM+146% QBTS +97% KULR +517% OPTT - 5% for a lot of the above is holding the key. When You buy in at a good prize, HOLD them. If you want to swing, sell for the quick small profit you're able to make.
Does anyone know ATOS origin SA-UNSP ADR? I mistakenly invest in it
Its ATOS origin SA-UNSP ADR. I think i bought wrong one?
ATOS.SBF went up but it didnt. What's the reason?
Could also be ATOS or AMMPower
Your post with title "ATOS - Peak 100 euro, now 4 eurocents." has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
Some people working at ATOS wrote 2 months ago that everything is running quite well, money and bonuses on time, getting new projects, finishing old ones... I think there could be value to be had. If I was big money investor I would try all my tricks to squeeze the rest of day traders out of this, then buy for lower price.
Europe willing to replace Microsoft ,AWS etc by "homemade" cloud service is bullish for ATOS. I buy everytime it dips a little.
Buy some more ATOS And PHAROL ATOS on France /europe PHAROL in Portugal/europe
Fuck it even ATOS is fuckin printing.
ATOS SE and since today TONNER DRONES / DELTA DRONES (ALTD). On ATOS I am up 250%, Tonner around 50%. The early birds bought it at 0.0015 Euro OTC it is already at 0.04
I'm down 83% on ATOS, losing hope for good. No reason to get out and eat the loss but.. it is definitely not a breeze
ATOS se, its pennystock but they will grow. Already went over 120% last 3-4 weeks. Its essential for france and they gonna have reverse split in may to get more attractive for big investors
You are partially correct, but do you understand what over-the-counter means and the risk associated with such purchases? Atos SE is primarily listed on **Euronext Paris** under the ticker symbol [**ATO.PA**](https://www.marketscreener.com/quote/stock/ATOS-SE-50911257/company-shareholders/) (they also have listings under other EUR exchanges). The company has not issued stocks directly in the U.S. or been listed on U.S. stock exchanges (like the NYSE or NASDAQ). However, Atos SE's shares are available to U.S. investors through the over-the-counter (OTC) market under the ticker **AEXAF**, this is inherently risky. Whereas in principle the OTC market should roughly track the performance of the listed equity, it is not always the case - especially in cases such as this, where the equity is doing incredibly well, the volume is and has been at 300% 65day averages, so the demand for shares is enormous on its listed markets. US mm of the otc market are taking the shares and selling back to EU. this is why the OTC market is going down. Hope I helped shed some light on the situation. Ask if you have any questions.
What profits? I'm red on literally everything except ATOS lol
ATOS SE, ABAT, Sunhydrogen, RZLV, SOBR, Genprex, Virpax. On the long term they either spike up or will develop. Time horizon... years.
European defense companies are hot! AEXAF and AEXAY...ATOS SE... French cyber security/Cloud service/ AI serves commercial and French Defense... just won another contract: https://www.tipranks.com/news/company-announcements/atos-wins-major-contract-to-secure-healthcare-it-systems Backed by French govt.